A modular strategy to develop HSA-based DOX prodrug nanoparticles for safe and effective tumor therapy
-
* Corresponding authors.
E-mail addresses: sunbingjun_spy@sina.com (B. Sun), xllbinbin@163.com (L. Li).
Citation:
Jialin Xing, Ziyi Wang, Yingbo Ma, Minglong Huang, Yafan Xiao, Lurong Zhang, Jin Sun, Zhonggui He, Bingjun Sun, Lingxiao Li. A modular strategy to develop HSA-based DOX prodrug nanoparticles for safe and effective tumor therapy[J]. Chinese Chemical Letters,
;2027, 38(1): 112386.
doi:
10.1016/j.cclet.2026.112386
S. Theivendran, S. Lazarev, C. Yu, Exploration 3 (2023) 20220086.
doi: 10.1002/EXP.20220086
Q. Yang, W. Huang, J.C. Hsu, et al., View 4 (2023) 20220085.
doi: 10.1002/VIW.20220085
Y. Zheng, X. You, L. Chen, et al., J. Biomed. Nanotechnol. 15 (2019) 1734–1743.
doi: 10.1166/jbn.2019.2798
M. Kciuk, A. Gielecinska, S. Mujwar, et al., Cells 12 (2023) 659. ´
doi: 10.3390/cells12040659
S. Peter, S. Alven, R.B. Maseko, et al., Molecules 27 (2022) 4478.
doi: 10.3390/molecules27144478
P.S. Rawat, A. Jaiswal, A. Khurana, et al., Biomed. Pharmacother. 139 (2021) 111708.
doi: 10.1016/j.biopha.2021.111708
E. Goormaghtigh, P. Huart, M. Praet, et al., Chem 35 (1990) 247–257.
C. Li, X. You, X. Xu, et al., Adv. Sci. 9 (2022) 2104134.
doi: 10.1002/advs.202104134
S. Zhang, Y. Zhang, W. Wang, et al., Chin. Chem. Lett. 35 (2024) 109658.
doi: 10.1016/j.cclet.2024.109658
N. Yokomichi, T. Nagasawa, A. Coler-Reilly, et al., Cell 26 (2013) 8–18.
doi: 10.1007/s13577-012-0057-0
R. Pettengell, C. Donatti, P. Hoskin, et al., Ann. Oncol. 19 (2008) 570–576.
doi: 10.1093/annonc/mdm543
M.T. Larsen, M. Kuhlmann, M.L. Hvam, et al., Mol. Cell. Ther. 4 (2016) 3.
doi: 10.1186/s40591-016-0048-8
B. Wu, J. Wang, Y. Chen, et al., ACS Biomater. Sci. Eng. 10 (2024) 743–761.
doi: 10.1021/acsbiomaterials.3c01744
M. Karimi, S. Bahrami, S.B. Ravari, et al., Expert Opin. Drug Deliv. 13 (2016) 1609–1623.
doi: 10.1080/17425247.2016.1193149
H. Cho, S.I. Jeon, C.H. Ahn, et al., Pharmaceutics 14 (2022) 728.
doi: 10.3390/pharmaceutics14040728
G. Murphy, D.J. Brayden, D.L. Cheung, et al., J. Control. Release 380 (2025) 375–395.
doi: 10.1016/j.jconrel.2025.01.035
W.J. Gradishar, S. Tjulandin, N. Davidson, et al., J. Clin. Oncol. 23 (2005) 7794–7803.
doi: 10.1200/JCO.2005.04.937
T.E. Stinchcombe, M.A. Socinski, C.M. Walko, et al., Cancer Chemother. Pharmacol. 60 (2007) 759–766.
doi: 10.1007/s00280-007-0423-x
A.M. Sofias, M. Dunne, G. Storm, et al., Adv. Drug Deliv. Rev. 122 (2017) 20–30.
doi: 10.1016/j.addr.2017.02.003
R. Wang, K.H. Kim, J. Yoo, et al., ACS Nano 16 (2022) 3045–3058.
doi: 10.1021/acsnano.1c10565
G. Yang, S.Z.F. Phua, W.Q. Lim, et al., Adv. Mater. 31 (2019) 1901513.
doi: 10.1002/adma.201901513
X. Zhang, M. Liu, Y. Hu, et al., Adv. Mater. 37 (2025) 2411515.
doi: 10.1002/adma.202411515
X.Y. Man, Z.W. Sun, S.H. Li, et al., Rare Met. 43 (2024) 6006–6022.
doi: 10.1007/s12598-024-02759-w
D. Agudelo, G. Bérubé, H.A. Tajmir-Riahi, Int. J. Biol. Macromol. 88 (2016) 354–360.
doi: 10.1016/j.ijbiomac.2016.03.060
L. Hao, Q. Zhou, Y. Piao, et al., J. Control. Release 330 (2021) 362–371.
doi: 10.1016/j.jconrel.2020.12.035
S.W. Chung, J.U. Choi, B.S. Lee, et al., Biomaterials 94 (2016) 1–8.
E.N. Hoogenboezem, C.L. Duvall, Adv. Drug Deliv. Rev. 130 (2018) 73–89.
doi: 10.1016/j.addr.2018.07.011
H. Gasoyan, E.R. Pfoh, R. Schulte, et al., JAMA Netw. Open. 7 (2024) e2433326.
doi: 10.1001/jamanetworkopen.2024.33326
T. Kruse, S. Østergaard, Nat. Chem. 16 (2024) 296–296.
R. Kelishadi, Nat. Rev. Endocrinol. 16 (2020) 405–406.
doi: 10.1038/s41574-020-0371-7
H.S. El-Sawy, A.M. Al-Abd, T.A. Ahmed, et al., ACS Nano 12 (2018) 10636–10664.
doi: 10.1021/acsnano.8b06104
L. Guo, H. Chen, J. Ding, et al., Exploration 3 (2023) 20230017.
doi: 10.1002/EXP.20230017
Y. Zeng, X. Zhang, D. Lin, et al., J. Hematol. Oncol. 14 (2021) 189.
doi: 10.1109/cloud53861.2021.00032
J. Wang, Y. Fan, S. Xu, et al., Chin. Chem. Lett. 37 (2026) 111607.
doi: 10.1016/j.cclet.2025.111607
E.S. Lee, K.T. Oh, D. Kim, et al., J. Control. Release 123 (2007) 19–26.
doi: 10.1016/j.jconrel.2007.08.006
Y.M. Bae, Y.I. Park, S.H. Nam, et al., Biomaterials 33 (2012) 9080–9086.
doi: 10.1016/j.biomaterials.2012.08.039
Y. Yu, S. Zuo, J. Song, et al., Nano Res. 17 (2024) 5491–5500.
doi: 10.1007/s12274-024-6533-5
Shufang Zheng , Deshuai Liu , Baoyuan Zhang , Yixin Sun , Zhenhua Du . Tunable hydrophobic branching modules enforce antitumor efficacy of docetaxel prodrug nanoassemblies. Chinese Chemical Letters, 2027, 38(1): 112981-. doi: 10.1016/j.cclet.2026.112981
Xiaopeng Han , Jiayin Li , Fei Li , Zhongyue Yuan , Hao Li , Lei Yang , Yan-Ming Xia , Chao Teng , Chao Qin , Lifang Yin . ROS-sensitive dihydroartemisinin prodrug amplify chemo-immunotherapy efficacy of doxorubicin by coordinating robust tumor cell immunogenic cell death and PD-L1 blockade. Chinese Chemical Letters, 2026, 37(2): 111335-. doi: 10.1016/j.cclet.2025.111335
Li Fu , Ziye Su , Shuyang Wu , Yanfen Cheng , Chuan Hu , Jinming Zhang . Redox-responsive hyaluronic acid-celastrol prodrug micelles with glycyrrhetinic acid co-delivery for tumor combination therapy. Chinese Chemical Letters, 2025, 36(5): 110227-. doi: 10.1016/j.cclet.2024.110227
Huijie An , Chen Yang , Zhihui Jiang , Junjie Yuan , Zhongming Qiu , Longhao Chen , Xin Chen , Mutu Huang , Linlang Huang , Hongju Lin , Biao Cheng , Hongjiang Liu , Zhiqiang Yu . Luminescence-activated Pt(Ⅳ) prodrug for in situ triggerable cancer therapy. Chinese Chemical Letters, 2024, 35(7): 109134-. doi: 10.1016/j.cclet.2023.109134
Jiaqi Huang , Renjiang Kong , Yanmei Li , Ni Yan , Yeyang Wu , Ziwen Qiu , Zhenming Lu , Xiaona Rao , Shiying Li , Hong Cheng . Feedback enhanced tumor targeting delivery of albumin-based nanomedicine to amplify photodynamic therapy by regulating AMPK signaling and inhibiting GSTs. Chinese Chemical Letters, 2024, 35(8): 109254-. doi: 10.1016/j.cclet.2023.109254
Yunkang Tong , Haiqiao Huang , Haolan Li , Mingle Li , Wen Sun , Jianjun Du , Jiangli Fan , Lei Wang , Bin Liu , Xiaoqiang Chen , Xiaojun Peng . Cooperative bond scission by HRP/H2O2 for targeted prodrug activation. Chinese Chemical Letters, 2024, 35(12): 109663-. doi: 10.1016/j.cclet.2024.109663
Lurong Zhang , Xin Wang , Xuan Li , Minglong Huang , Bowen Zhang , Shengyao Xu , Jialin Xing , Yafan Xiao , Yi Zheng , Zhenzhen Zhao , Jin Sun , Zhonggui He , Lingxiao Li , Bingjun Sun . Fine-tuning PEGylation: Leveraging the self-assembly stability and targeting efficiency of biotinylated-paclitaxel prodrug nanoassemblies. Chinese Chemical Letters, 2026, 37(7): 111694-. doi: 10.1016/j.cclet.2025.111694
Hongyi Huang , Siyao Che , Wenjie Zhou , Yunchu Zhang , Weiling Zhuo , Xijing Yang , Songping Zheng , Jiagang Liu , Xiang Gao . Apatinib potentiates doxorubicin with cRGD-functionalized pH-sensitive micelles against glioma. Chinese Chemical Letters, 2025, 36(5): 110084-. doi: 10.1016/j.cclet.2024.110084
Xin Liu , Haoran Zhu , Yi Wang , Haili Zhang , Yujie Li , Hongcheng Gao , Yi Han , Dejin Wang , Yunsheng Xia . Carbon dots-embedded hydrogel ratiometric fluorescent platform for portable determination of doxorubicin in clinical samples. Chinese Chemical Letters, 2026, 37(2): 111891-. doi: 10.1016/j.cclet.2025.111891
Jia Wang , Yunxiu Fan , Shilin Xu , Zhouxue Wu , Tian Hu , Yun Lu , Yue Li , Kang Xiong , Hongjun Deng , Jingrong Huang , Bo Yang , Shaozhi Fu . Self-propelled biomotors co-deliver doxorubicin liposomes and aPD-1 antibody to fight breast cancer. Chinese Chemical Letters, 2026, 37(2): 111607-. doi: 10.1016/j.cclet.2025.111607
Tingting Li , Yunchu Zhang , Siyao Che , Yuanyuan Zhang , Yin Wu , Weiling Zhuo , Xifeng Zhang , Wanyu Wang , Jiaqi Zheng , Xiang Gao , Yuzhu Hu , Ting Luo . Stimuli-responsive codelivery of apatinib and doxorubicin potentiates chemotherapy efficacy in breast cancer. Chinese Chemical Letters, 2026, 37(9): 111936-. doi: 10.1016/j.cclet.2025.111936
Menghua Xiang , Fen Yang , Peng Chen , Jiaoyu Chen , Jianzhong Zhang , Jiayi Yang , Yilin Liu , Qianqian Zhang , Jiang Pi , Peiyan Yuan , Shao Q Yao , Liqian Gao . Tumor microenvironment-responsive self-assembled nanomedicine for reversible covalent targeting of BCR-ABL kinase. Chinese Chemical Letters, 2026, 37(2): 111423-. doi: 10.1016/j.cclet.2025.111423
Huihui Wei , Yiming Niu , Mingli Xie , Weining He , Min Chen , Tenghui Wang , Qinhong Jiang , Panfei Xing , Chunming Wang . Photo-bioactivated azido fluorophores for passive and active cell imaging. Chinese Chemical Letters, 2026, 37(6): 111409-. doi: 10.1016/j.cclet.2025.111409
Ning Tian , Haoyu Ju , Qian Hu , Qifeng Hou , Yiping Lu , Yu Liu , Jinmei Huang , Zhong-Hong Zhu , Bin Zhang , Jin Huang , Ming-Hua Zeng . Solvothermal domino synthesis of an ER-targeted iron(Ⅱ) complex for inducing immunogenic cell death. Chinese Chemical Letters, 2026, 37(6): 111038-. doi: 10.1016/j.cclet.2025.111038
Xiangqian Cao , Chenkai Yang , Xiaodong Zhu , Mengxin Zhao , Yilin Yan , Zhengnan Huang , Jinming Cai , Jingming Zhuang , Shengzhou Li , Wei Li , Bing Shen . Synergistic enhancement of chemotherapy for bladder cancer by photothermal dual-sensitive nanosystem with gold nanoparticles and PNIPAM. Chinese Chemical Letters, 2024, 35(8): 109199-. doi: 10.1016/j.cclet.2023.109199
Jiangshan Xu , Weifei Zhang , Zhengwen Cai , Yong Li , Long Bai , Shaojingya Gao , Qiang Sun , Yunfeng Lin . Tetrahedron DNA nanostructure/iron-based nanomaterials for combined tumor therapy. Chinese Chemical Letters, 2024, 35(11): 109620-. doi: 10.1016/j.cclet.2024.109620
Shuheng Zhang , Yuanyuan Zhang , Wanyu Wang , Yuzhu Hu , Xinchuan Chen , Bilan Wang , Xiang Gao . A combination strategy of DOX and VEGFR-2 targeted inhibitor based on nanomicelle for enhancing lymphoma therapy. Chinese Chemical Letters, 2024, 35(12): 109658-. doi: 10.1016/j.cclet.2024.109658
Yaqi Li , Yixin Sun , Qinglong Yan , Wenjing Wang , Shuo Wang , Qing Wang , Danping Wang , Jun Yuan , Jin Sun , Zhonggui He , Zhenbao Li , Bingjun Sun . Redox-triggered prodrug nanoassemblies with high tumor selectivity and biocompatibility break through antitumor dilemma of paclitaxel. Chinese Chemical Letters, 2026, 37(5): 111350-. doi: 10.1016/j.cclet.2025.111350
Xuanbo Zhang , Feng Fang , Na Li , Huicong Zhang , Kaiyuan Wang , Zhiqiang Yu , Jin Sun . From reversible to irreversible: Albumin-hitchhiking gemcitabine prodrugs for enhanced antitumor efficacy and reduced toxicity. Chinese Chemical Letters, 2026, 37(2): 111452-. doi: 10.1016/j.cclet.2025.111452
Fa Wang , Yu Chen , Hui Chao . Ruthenium(II) Complexes as Photoactivated Chemo-Prodrugs for Hypoxic Tumor Therapy. University Chemistry, 2025, 40(7): 200-212. doi: 10.12461/PKU.DXHX202410024